What is acute myocardial ischemia without necrosis?

It is a condition characterized by reduced coronary blood flow without irreversible (necrotic) myocardial injury, typically transient and potentially reversible.

How is acute myocardial ischemia without necrosis diagnosed?

Diagnosis is based on symptoms, ECG changes suggestive of ischemia, absence of elevated cardiac biomarkers, imaging tests, and, in selected cases, coronary angiography.

What are the main treatments?

Antiplatelet agents, beta-blockers, nitrates, calcium channel blockers in cases of vasospasm, and management of risk factors. In high-risk cases, coronary angioplasty may be indicated.

What complications can it cause?

Myocardial infarction, malignant arrhythmias, acute heart failure, especially in the absence of treatment.

What is the prognosis?

The prognosis is generally favorable if treated early; secondary prevention is crucial to reduce the risk of recurrence.

L'angolo del dottorino

Change Language:

Index

Search the site... Advanced search

✖

Acute Myocardial Ischemia Without Necrosis

Article written and reviewed by Dr Luca Moretti

Acute myocardial ischemia without necrosis is a clinical condition characterized by insufficient oxygen supply to the myocardium without the occurrence of the cellular necrosis typical of myocardial infarction. It represents a transient and reversible condition, but may be an early warning sign of major cardiovascular events if not properly managed.

This form of ischemia often presents as unstable angina or with electrocardiographic changes suggestive of ischemia, in the absence of cardiac biomarkers indicative of irreversible myocardial damage.

Pathophysiology

Myocardial ischemia occurs when the balance between oxygen demand and supply to the myocardium is disrupted. The main mechanisms include:

Reduced oxygen supply: critical coronary stenosis, coronary spasm, or altered microcirculation.
Increased myocardial demand: tachycardia, hypertension, or left ventricular hypertrophy.
Autonomic imbalance: endothelial dysfunction and reduced coronary reserve.

Causes

Acute myocardial ischemia without necrosis can result from several factors:

Coronary atherosclerotic disease: critical stenoses reducing blood flow.
Coronary spasm (Prinzmetal’s angina): transient vasoconstriction that reduces oxygen supply.
Coronary microangiopathy: microvascular dysfunction compromising perfusion.
Metabolic stress conditions: anemia, hypoxia, or hyperthyroidism.
Tachyarrhythmias: atrial fibrillation or non-sustained ventricular tachycardia.

Clinical Presentation

Patients may present with symptoms similar to those of myocardial infarction, but without necrosis:

Oppressive chest pain, often at rest or following stress.
Dyspnea, related to transient ventricular dysfunction.
Pallor and profuse sweating in more severe cases.
Feeling of instability or presyncope, due to cerebral hypoperfusion.

Diagnosis

The diagnosis of myocardial ischemia without necrosis is based on:

Electrocardiogram (ECG)
It may show transient ST segment depression or T wave inversion, without evidence of myocardial necrosis.
Cardiac biomarkers
Troponins are not elevated, distinguishing this condition from myocardial infarction.
Imaging tests
Stress echocardiography or myocardial scintigraphy may reveal perfusion abnormalities.
Coronary angiography
Indicated in high-risk patients to identify significant stenoses or microvascular dysfunction.

Treatment

The management of myocardial ischemia without necrosis aims to prevent progression to myocardial infarction:

1. Pharmacological therapy

Antiplatelet agents: aspirin and clopidogrel to prevent thrombosis.
Beta-blockers: reduce myocardial oxygen consumption.
Nitrates: improve coronary blood flow and reduce symptoms.
Calcium channel blockers: indicated in patients with coronary spasm.

2. Invasive strategies

In high-risk patients, coronary angiography is recommended to evaluate the need for coronary angioplasty.

Complications

If left untreated, acute myocardial ischemia without necrosis can evolve into:

Acute myocardial infarction, with documented necrosis.
Transient ventricular dysfunction, with risk of heart failure.
Malignant arrhythmias, such as ventricular fibrillation or sustained ventricular tachycardia.

Prognosis

The prognosis depends on the underlying cause and the timeliness of therapy. Patients with untreated critical coronary stenoses have a higher risk of future ischemic events. Secondary prevention with risk factor modification and pharmacological therapy is essential to improve long-term outcomes.

References

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599-3726.
Ibanez B, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119-177.
Fuster V, et al. Management of patients with non-ST elevation acute coronary syndromes. Circulation. 2011;123(11):1287-1302.
Camici PG, et al. Microvascular Angina and Coronary Microvascular Dysfunction. J Am Coll Cardiol. 2020;75(20):2419-2432.
Roffi M, et al. 2015 ESC Guidelines for Non-ST Elevation Acute Coronary Syndromes. Eur Heart J. 2016;37(3):267-315.
Rogers WJ, et al. Relationship between infarct size and clinical outcomes in acute myocardial infarction. Am J Cardiol. 2015;115(8):986-993.
Gibbons RJ, et al. ACC/AHA Guidelines for the Management of Patients with Chronic Stable Angina. Circulation. 2002;106(3):1795-1802.
Amsterdam EA, et al. 2014 AHA/ACC Guidelines for NSTEMI. J Am Coll Cardiol. 2014;64(24):e139-e228.
Ferguson TB, et al. 2019 ACC/AHA/ASE guidelines for the management of ST-elevation myocardial infarction. Circulation. 2019;139(17):e149-e174.
Chiarella F, et al. Cardiac arrest. G Ital Cardiol. 2003;4(11):8789-8796.